Dialysis access strategies: AVF, stenosis, thrombosis & next-gen solutions

Catch this PVI 2025 session replay on evolving strategies for the hemodialysis lifeline. Endovascular AVFs are put into perspective, with limited, device-specific evidence, similar outcomes to surgery, and higher costs restricting broader adoption. In contrast, percutaneous AVFs show strong safety and creation success, but require structured programs to address reintervention and functionality challenges, while early-generation devices faced economic barriers. 

The session also looks ahead to next-generation technologies in clinical evaluation and introduces a biological graft designed for rapid use with promising patency and low infection rates. An algorithm for AVF/AVG stenosis management—covered stents, DCBs, or surgery—rounds out the practical approach, followed by a focused discussion on recurrent thrombosis.

Hit play to see what works, what fails, and what's next.